When the cardiovascular risk conversation came up after menopause, it felt abstract — until it didn't. Finding out there's a molecule the body quietly stops making enough of, one that touches the heart, the mitochondria, and blood pressure all at once, made the post-menopause risk picture feel less like bad luck and more like biology that can at least be understood. That shift from helpless to informed matters.
Learn more about Rose →Taurine is technically a sulfonic acid derived from the amino acid cysteine, and unlike most amino acids it is not incorporated into proteins — it acts as a free molecule inside cells. It is found in high concentrations in the heart, skeletal muscle, brain, and retina, which hints at where it does its most important work. Understanding this distinction matters because it explains why taurine has such wide-ranging physiological effects rather than one narrow job.
The 2023 Singh et al. study published in Science measured taurine concentrations across multiple species and found that blood taurine levels in humans decline by approximately 80% between early adulthood and older age. This is not a marginal shift — it represents a substantial loss of a molecule the body relies on for multiple regulatory functions. The researchers demonstrated that restoring taurine in middle-aged mice extended both healthspan and lifespan, which is what drew broader scientific attention to this finding.
Animal studies have shown that estrogen modulates taurine transporter expression and taurine metabolism in cardiac and hepatic tissue, suggesting that the hormonal environment shapes how efficiently taurine is produced, retained, and used. When estrogen declines at menopause, this regulatory influence is reduced, potentially compounding the age-related decline in taurine that is already underway. This is the specific intersection that makes taurine research relevant to perimenopause rather than just general aging.
Taurine stabilises intracellular calcium handling in cardiomyocytes, supports healthy blood pressure by modulating the renin-angiotensin system, and has demonstrated anti-inflammatory and antioxidant effects in vascular tissue across multiple animal and human studies. These are exactly the physiological domains where postmenopausal women face elevated risk as estrogen's protective effects withdraw. Several small randomised controlled trials in humans have shown taurine supplementation reduces systolic blood pressure and markers of oxidative stress in adults with hypertension.
Taurine is required for the proper modification of mitochondrial transfer RNAs, and without adequate taurine, mitochondrial protein synthesis becomes inefficient, impairing the electron transport chain and reducing cellular energy output. This matters acutely in menopause because estrogen normally supports mitochondrial biogenesis and efficiency, so the combined loss of estrogen and declining taurine creates a kind of double pressure on mitochondrial capacity. Impaired mitochondrial function is increasingly understood as a driver of fatigue, metabolic slowdown, and even cognitive changes in midlife women.
Multiple animal studies and several small human trials have found that taurine improves insulin sensitivity, reduces fasting glucose, and appears to support pancreatic beta-cell function. Given that insulin resistance rises after menopause — partly due to estrogen withdrawal and partly to age-related changes in body composition — this metabolic dimension of taurine is attracting genuine research interest. A 2012 meta-analysis in Amino Acids found consistent blood pressure and lipid benefits from taurine supplementation, with glucose effects emerging as a secondary signal worth investigating further.
Physical activity increases taurine biosynthesis and upregulates taurine transporters in skeletal and cardiac muscle, which researchers now believe contributes to some of exercise's well-established cardiovascular benefits. This creates an interesting feedback loop: sedentary behaviour accelerates taurine decline, while regular movement helps maintain it. For perimenopausal and postmenopausal women already being advised to prioritise exercise for heart and bone health, the taurine connection gives that advice an additional mechanistic layer.
Taurine is found in meaningful amounts in shellfish, dark poultry meat, beef, and to a lesser extent fish, but it is essentially absent from plant foods because plants do not synthesise it. While the human body can produce taurine endogenously from cysteine and methionine, this synthetic capacity is limited and declines further with age, meaning dietary intake becomes more relevant over time. Women following vegan or plant-forward diets may be more vulnerable to taurine insufficiency and represent a group where monitoring this molecule may be particularly worth considering.
The honest caveat to all of this is that most of the compelling taurine research has been conducted in animal models or in mixed adult populations rather than specifically in peri- or postmenopausal women — meaning direct evidence for this group is still limited. The mechanistic case is coherent and grounded in real physiology, but science requires that the specific population be studied before confident clinical guidance can be given. Several trials are currently in design or early stages, and this is a space worth watching over the next five years rather than a closed chapter.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.